Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China.
Department of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.
Int J Mol Sci. 2022 Mar 24;23(7):3548. doi: 10.3390/ijms23073548.
Ran Binding Protein 2 (RanBP2 or Nucleoporin358) is one of the main components of the cytoplasmic filaments of the nuclear pore complex. Mutations in the gene are associated with acute necrotizing encephalopathy type 1 (ANE1), a rare condition where patients experience a sharp rise in cytokine production in response to viral infection and undergo hyperinflammation, seizures, coma, and a high rate of mortality. Despite this, it remains unclear howRanBP2 and its ANE1-associated mutations contribute to pathology. Mounting evidence has shown that RanBP2 interacts with distinct viruses to regulate viral infection. In addition, RanBP2 may regulate innate immune response pathways. This review summarizes recent advances in our understanding of how mutations in contribute to ANE1 and discusses how RanBP2 interacts with distinct viruses and affects viral infection. Recent findings indicate that RanBP2 might be an important therapeutic target, not only in the suppression of ANE1-driven cytokine storms, but also to combat hyperinflammation in response to viral infections.
Ran 结合蛋白 2(RanBP2 或核孔蛋白 358)是核孔复合物细胞质丝的主要成分之一。基因中的突变与急性坏死性脑病 1 型(ANE1)有关,这是一种罕见的病症,患者在病毒感染时会经历细胞因子产生的急剧增加,并经历过度炎症、癫痫发作、昏迷和高死亡率。尽管如此,RanBP2 及其与 ANE1 相关的突变如何导致病理学仍不清楚。越来越多的证据表明,RanBP2 与不同的病毒相互作用以调节病毒感染。此外,RanBP2 可能调节先天免疫反应途径。这篇综述总结了我们对基因突变如何导致 ANE1 的理解的最新进展,并讨论了 RanBP2 如何与不同的病毒相互作用以及如何影响病毒感染。最近的发现表明,RanBP2 可能是一个重要的治疗靶点,不仅可以抑制 ANE1 驱动的细胞因子风暴,还可以对抗病毒感染引起的过度炎症。